Alumis shares sink after the California-based biotech says envudeucitinib failed to meet the primary endpoint of a mid-stage ...

The biotech sector has a new catalyst beyond GLP-1 drugs. Moderna Inc MRNA and Merck & Co Inc’s MRK positive Phase 3 results ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Twenty-five biotechs have used the IPO route to go public this year—with five of those debuts occurring this month alone.

The collaboration will integrate HiRO’s data science and clinical operations experience with Differentia’s simulation ...

Beyond terms like "met endpoint" or "statistically significant," understanding how to read clinical trial results and what ...

Join us for Open Doors — as we approach the start of a new year, what trends will be impacting the biotech industry in 2025? And how can biotech executives, communications and marketing officers get ...

The Virtual Investor "Why Now" On-Demand Conference, hosted by Virtual Investor Co. in partnership with JTC Team, wrapped up ...

Sidhu’s latest SPAC, dubbed JATT III Acquisition, listed on the Nasdaq this morning via a $60 million IPO. The company is ...

A new report found that the sizes of seed rounds and Series A financings for Massachusetts biotech startups are going in ...